CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. 1998

G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
Section of Virology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom.

The coreceptors used by primary syncytium-inducing (SI) human immunodeficiency virus type 1 isolates for infection of primary macrophages were investigated. SI strains using only CXCR4 replicated equally well in macrophages with or without CCR5 and were inhibited by several different ligands for CXCR4 including SDF-1 and bicyclam derivative AMD3100. SI strains that used a broad range of coreceptors including CCR3, CCR5, CCR8, CXCR4, and BONZO infected CCR5-deficient macrophages about 10-fold less efficiently than CCR5(+) macrophages. Moreover, AMD3100 blocked infection of CCR5-negative macrophages by these strains. Our results therefore demonstrate that CXCR4, as well as CCR5, is used for infection of primary macrophages but provide no evidence for the use of alternative coreceptors.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019713 Receptors, CCR5 CCR receptors with specificity for CHEMOKINE CCL3; CHEMOKINE CCL4; and CHEMOKINE CCL5. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; MAST CELLS; and NK CELLS. The CCR5 receptor is used by the HUMAN IMMUNODEFICIENCY VIRUS to infect cells. Antigens, CD195,CC Chemokine Receptor 5,CCR5 Receptors,CD195 Antigens,CC-CKR5,CCR5 Receptor,CKR5 Receptors,Receptors, CKR5,Receptor, CCR5
D019718 Receptors, CXCR4 CXCR receptors with specificity for CXCL12 CHEMOKINE. The receptors may play a role in HEMATOPOIESIS regulation and can also function as coreceptors for the HUMAN IMMUNODEFICIENCY VIRUS. CXC Chemokine Receptor 4,CXCR4 Receptors,Fusin,CXCR4 Receptor,LESTR Receptor,Leukocyte-Derived Seven-Transmembrane Domain Receptor,Receptor, LESTR,Leukocyte Derived Seven Transmembrane Domain Receptor,Receptor, CXCR4

Related Publications

G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
September 1998, Journal of immunology (Baltimore, Md. : 1950),
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
November 2004, Journal of virology,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
August 2000, Journal of virology,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
May 2000, Journal of virology,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
June 2005, Current HIV/AIDS reports,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
November 2005, Journal of virology,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
April 2011, Virology journal,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
December 2001, Journal of virology,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
February 2005, Journal of virology,
G Simmons, and J D Reeves, and A McKnight, and N Dejucq, and S Hibbitts, and C A Power, and E Aarons, and D Schols, and E De Clercq, and A E Proudfoot, and P R Clapham
November 1998, Journal of virology,
Copied contents to your clipboard!